Skip to main content
OpenTrials

Clinical trial condition

Central Line Associated Blood Stream Infections (CLABSI)

Explore clinical trials studying Central Line Associated Blood Stream Infections (CLABSI). Study availability and eligibility vary by location and protocol.

4 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Central Line Associated Blood Stream Infections (CLABSI) trial results

Recruiting

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

NCT06822426

Conditions
Central Line Associated Blood Stream Infections (CLABSI)
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • MedStar Health Research Institute Washington D.C., District of Columbia, United States
  • Bioresearch Partner Doral, Florida, United States
  • Emory University Hospital - GCRC Atlanta, Georgia, United States
View all 22 locations
View Trial Details
Recruiting

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

NCT07108660

Conditions
Central Line Associated Blood Stream Infections (CLABSI), Cross Infection, Disease Attributes, +4 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • St. Mary Medical Center Apple Valley, California, United States
  • Providence Saint Joseph Medical Center Burbank, California, United States
  • St. Jude Medical Center Fullerton, California, United States
View all 19 locations
View Trial Details

Related conditions